Global Humanized Mouse Model Markets, 2021-2025: Innovative Applications of Humanized Mouse Models Driving Growth - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Humanized Mouse Model Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
The humanized mouse model market is poised to grow by $ 119.20 mn during 2021-2025, decelerating at a CAGR of over 14%
This study identifies the innovative applications of humanized mouse models as one of the prime reasons driving the humanized mouse model market growth during the next few years. The market is driven by the rising focus on preventing the spread of pandemics and growing adoption of personalized medicine.
The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The humanized mouse model market analysis includes product and end-user segments and geographic landscape.
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Envigo, genOway, ingenious targeting laboratory, JSR Corp., Taconic Biosciences Inc., The Jackson Laboratory, and TRANS GENIC Inc..
Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Key Topics Covered:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Genetically humanized mouse model - Market size and forecast 2020-2025
- Cell-based humanized mouse model - Market size and forecast 2020-2025
- Market opportunity by Product
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Pharmaceutical and biotechnology companies - Market size and forecast 2020-2025
- CROs - Market size and forecast 2020-2025
- Academic and research institutions - Market size and forecast 2020-2025
- Market opportunity by End-user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Champions Oncology Inc.
- Charles River Laboratories International Inc.
- Creative Biolabs
- Envigo
- genOway
- ingenious targeting laboratory
- JSR Corp.
- Taconic Biosciences Inc.
- The Jackson Laboratory
- TRANS GENIC Inc.
For more information about this report visit https://www.researchandmarkets.com/r/kv21zf
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Editor Details
-
Company:
- Businesswire